XML 64 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Pay vs Performance Disclosure
12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Pay vs Performance Disclosure [Table]      
Pay vs Performance [Table Text Block]
Pay versus Performance ("PvP")
As required by Item 402(v) of Regulation
S-K,
we are providing the following information regarding the relationship between executive compensation and our financial performance for each of the last three completed calendar years. In determining the "compensation actually paid" (“CAP”) to our NEOs, we are required to make various adjustments to amounts that have been previously reported in the Summary Compensation Table in previous years, as the SEC's valuation methods for this section differ from those required in the Summary Compensation Table. The PvP table below summarizes compensation values both previously reported in our Summary Compensation Table, as well as the adjusted values required in this section for the 2020, 2021 and 2022 calendar years. Note that for our NEOs other than our Chief Executive Officer (the "CEO"), compensation is reported as an average. The Human Capital & Compensation Committee does not utilize CAP as the basis for making compensation decisions, and it evaluates performance for purposes of incentive payouts using a more comprehensive set of metrics than required by the SEC for purposes of this disclosure.
 
Year
 
Summary
Compensation
Table Total
for Mr.
Clyburn(1)($)
   
Summary
Compensation
Table Total
for Mr.
Fibig(1)($)
   
Compensation
Actually Paid
to Mr.
Clyburn(1)($)
   
Compensation
Actually Paid
to Mr.
Fibig(1)($)
   
 
Average
Summary
Compensation
Table Total
for
Non-CEO

NEOs
($)(2)(3)(4)
   
Average
Compensation
Actually Paid
to
Non-CEO

NEOs
($)(2)(3)(4)
   
Value of Initial
Fixed $100
Investment Based
On:
   
Net Income

(Loss) ($ in
Millions)(6)
   
Currency
Neutral
Sales
Growth
(%)(7)
 
                                        
Total
Shareholder
Return ($)
   
Peer Group
Total
Shareholder
Return
($)(5)
             
(a)
    (b)       (c)       (d)       (e)       (f)       (g)       (h)       (i)       (j)       (k)  
2022
    19,271,654       11,800,037       15,327,178       8,911,848       5,369,203       3,743,462       88       110       (1,871)       9.3%  
2021
            9,767,380               12,525,503       3,148,004       3,170,578       123       151       270       7.8%  
2020
            7,731,147               4,403,472       2,060,046       1,286,913       87       117       363       0.0%  
 
(1)
Mr. Clyburn joined as our CEO and as a director and Chair of the Board on February 14, 2022. Mr. Fibig ceased serving as our CEO and as a director and Chair of the Board as of February 14, 2022 and departed the company on March 14, 2022.
 
(2)
Non-CEO
NEO's for 2022 were: Mr. Glenn Richter, Mr. Nicolas Mirzayantz, Ms. Deborah Borg, Mr. Ralf Finzel and Mr. Francisco Fortanet.
 
(3)
Non-CEO
NEO's for 2021 were: Mr. Glenn Richter, Mr. Nicolas Mirzayantz, Mr. Francisco Fortanet, Dr. Susana Suarez Gonzalez, Mr. Rustom Jilla (Former CFO), Ms. Kathy Fortmann (Former President, Nourish) and Ms. Anne Chwat (Former General Counsel).
 
(4)
Non-CEO
NEO's for 2020 were: Mr. Nicolas Mirzayantz, Mr. Rustom Jilla (Former CFO), Ms. Anne Chwat (Former General Counsel), Mr. Matthias Haeni (Former Divisional CEO, Taste) and Mr. Richard O'Leary (Former CFO).
 
(5)
The Peer Group used for this calculation was the S&P 500 Specialty Chemicals Index which is also reported on Form
10-K
in the Performance Graph.
 
(6)
Net Income (Loss) reflected represents GAAP Net (Loss) Income as reported on Form
10-K
in the Results of Operations Statement. The 2022 Net Loss of ($
1.871
billion) reflects a $
2.250
billion impairment of goodwill in the Health & Biosciences reporting unit. Excluding all
one-time
adjustments for 2022, the Adjusted Net Income was $
828
million.
 
(7)
Currency Neutral Sales Growth is the company-selected performance measure, per the requirements of Item 402(v) of Regulation
S-K
and is discussed and reported in the CD&A section of the Proxy under Corporate Performance.
Mr. Clyburn Compensation
To determine the amounts in column (d) in the PvP table, the following amounts were deducted from and added to (as applicable) Mr. Clyburn's total compensation as reported in the Summary Compensation Table ("SCT"), in accordance with Item 402(v) of Regulation
S-K.
 
Year
 
SCT Total
for Mr.
Clyburn($)
   
SCT Reported
Equity Award
Value for Mr.
Clyburn($)
   
Equity Award
Adjustments
for Mr.
Clyburn($)(1)
   
 
SCT Reported
Change in the
Actuarial Present
Value of Pension
Benefits for Mr.
Clyburn($)
   
Pension Benefit
Adjustments
for Mr.
Clyburn($)
   
Compensation
Actually Paid
to Mr.
Clyburn($)
 
2022
    19,271,654       (16,511,105)       12,566,629                   15,327,178  
 
(1)
Represents the year-over-year change in the fair value of equity awards to Mr. Clyburn as summarized below:
 
Year
 
Year End Fair
Value of
Unvested Equity
Awards Granted
in the Year($)
   
Year over Year
Change in Fair
Value of
Outstanding
Unvested Equity
Awards Granted
in Prior Years($)
   
Fair Value as of
Vesting Date of
Equity Awards
Granted and
Vested in the
Year($)
   
Year over Year
Change in Fair
Value of Equity
Awards Granted
in Prior Years
that Vested in
the Year($)
   
Fair Value at the
End of the Prior
Year of Equity
Awards that
Failed to Meet
Vesting
Conditions in
the Year($)
   
 
Value of
Dividends or
other Earnings
Paid on Equity
Awards not
Otherwise
Reflected in Fair
Value or Total
Compensation ($)
   
Total Equity
Award
Adjustments($)
 
2022
    12,566,629                                     12,566,629  
In the table above, the unvested equity values are computed in accordance with the methodology used for financial reporting purposes, and for unvested awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the last day of the year.
Mr. Fibig Compensation
To determine the amounts in column (e) in the PvP table, the following amounts were deducted from and added to (as applicable) Mr. Fibig's total compensation as reported in the Summary Compensation Table ("SCT"), in accordance with Item 402(v) of Regulation
S-K.
 
Year
 
SCT Total for
Mr. Fibig($)
   
SCT Reported
Equity Award
Value for
Mr. Fibig($)
   
Equity Award
Adjustments for
Mr. Fibig($)(1)
   
 
SCT Reported
Change in the
Actuarial Present
Value of Pension
Benefits for
Mr. Fibig($)
   
Pension Benefit
Adjustments for
Mr. Fibig($)
   
Compensation
Actually Paid to
Mr. Fibig($)
 
2022
    11,800,037             (2,888,189)                   8,911,848  
2021
    9,767,380       (5,723,445)       8,481,568                   12,525,503  
2020
    7,731,147       (5,031,869)       1,704,194                   4,403,472  
 
(1)
Represents t
h
e year-over-year change in the fair value of equity awards to Mr. Fibig as summarized below:
 
Year
 
Year End Fair
Value of Unvested
Equity Awards
Granted in the
Year($)
   
Year over Year
Change in Fair
Value of
Outstanding
Unvested
Equity Awards
Granted in
Prior Years($)
   
Fair Value as of
Vesting Date of
Equity Awards
Granted and
Vested in the
Year($)
   
Year over Year
Change in Fair
Value of Equity
Awards Granted
in Prior Years
that Vested in
the Year($)
   
Fair Value at the
End of the Prior
Year of Equity
Awards that
Failed to Meet
Vesting
Conditions in
the Year($)
   
 
Value of
Dividends or
other Earnings
Paid on Equity
Awards not
Otherwise
Reflected in Fair
Value or Total
Compensation ($)
   
Total Equity
Award
Adjustments($)
 
2022
                      (2,888,189)                   (2,888,189)  
2021
    5,856,147       2,598,655       320,729       642,604       (1,132,404)       195,837       8,481,568  
2020
    3,862,811       (1,093,545)             (471,361)       (771,141)       177,430       1,704,194  
In the table above, the unvested equity values are computed in accordance with the methodology used for financial reporting
p
urposes, and for unvested awards subject to performance-based vesting conditions,
based
on the probable outcome of such performance-based vesting conditions as of the last day of the year.
Average
Non-CEO
NEO Compensation
To determine the amounts in column (g) in the PvP table, the following amounts were deducted from and added to (as applicable) our
Non-CEO
NEO's average total compensation as reported in the Summary Compensation Table ("SCT"), in accordance with Item 402(v) of Regulation
S-K.
 
Year
 
Average SCT
Total for
Non-CEO

NEOs($)
   
Average SCT
Reported Equity
Award Value for
Non-CEO NEOs($)
   
Average Equity
Award
Adjustments
for
Non-CEO

NEOs ($)(1)
   
 
SCT Reported
Average Change in
the Actuarial
Present Value of
Pension Benefits
for
Non-CEO($)

NEOs($)
   
Average Pension
Benefit
Adjustments for
Non-CEO

NEOs($)(2)
   
Average
Compensation
Actually Paid to
Non-CEO NEOs($)
 
2022
    5,369,203       (3,085,500)       1,459,759                   3,743,462  
2021
    3,148,004       (1,514,851)       1,539,657       (2,232)             3,170,578  
2020
    2,060,046       (1,056,088)       349,261       (66,306)             1,286,913  
 
(1)
Represents the average of the year-over-year change in the fair value of equity awards to
our
Non-CEO
NEO's as summarized below.
 
(2)
There is no service cost or prior service cost adjustment for pension benefits as the pension plan benefits applicable to NEOs were frozen for additional accruals as of December 31, 2007.
 
Year
 
Year End Fair
Value of
Unvested Equity
Awards Granted
in the Year($)
   
Year over Year
Change in Fair
Value of
Outstanding
Unvested
Equity Awards
Granted in
Prior Years($)
   
Fair Value as of
Vesting Date of
Equity Awards
Granted and
Vested in the
Year($)
   
Year over Year
Change in Fair
Value of Equity
Awards Granted
in Prior Years
that Vested in
the Year($)
   
Fair Value at the
End of the Prior
Year of Equity
Awards that
Failed to Meet
Vesting
Conditions in
the Year($)
   
 
Value of
Dividends or
other Earnings
Paid on Equity
Awards not
Otherwise
Reflected in Fair
Value or Total
Compensation
($)
   
Total Equity
Award
Adjustments($)
 
2022
    2,192,872       (220,228)       91,429       (337,314)       (282,833)       15,833       1,459,759  
2021
    1,199,240       198,103       64,492       199,759       (137,688)       15,752       1,539,657  
2020
    733,010       (154,763)             (150,632)       (110,451)       32,097       349,261  
 
   
Company Selected Measure Name Currency Neutral Sales Growth    
Named Executive Officers, Footnote [Text Block]
(1)
Mr. Clyburn joined as our CEO and as a director and Chair of the Board on February 14, 2022. Mr. Fibig ceased serving as our CEO and as a director and Chair of the Board as of February 14, 2022 and departed the company on March 14, 2022.
 
(2)
Non-CEO
NEO's for 2022 were: Mr. Glenn Richter, Mr. Nicolas Mirzayantz, Ms. Deborah Borg, Mr. Ralf Finzel and Mr. Francisco Fortanet.
 
(3)
Non-CEO
NEO's for 2021 were: Mr. Glenn Richter, Mr. Nicolas Mirzayantz, Mr. Francisco Fortanet, Dr. Susana Suarez Gonzalez, Mr. Rustom Jilla (Former CFO), Ms. Kathy Fortmann (Former President, Nourish) and Ms. Anne Chwat (Former General Counsel).
 
(4)
Non-CEO
NEO's for 2020 were: Mr. Nicolas Mirzayantz, Mr. Rustom Jilla (Former CFO), Ms. Anne Chwat (Former General Counsel), Mr. Matthias Haeni (Former Divisional CEO, Taste) and Mr. Richard O'Leary (Former CFO).
   
Peer Group Issuers, Footnote [Text Block] The Peer Group used for this calculation was the S&P 500 Specialty Chemicals Index which is also reported on Form
10-K
in the Performance Graph.
   
Adjustment To PEO Compensation, Footnote [Text Block]
Mr. Clyburn Compensation
To determine the amounts in column (d) in the PvP table, the following amounts were deducted from and added to (as applicable) Mr. Clyburn's total compensation as reported in the Summary Compensation Table ("SCT"), in accordance with Item 402(v) of Regulation
S-K.
 
Year
 
SCT Total
for Mr.
Clyburn($)
   
SCT Reported
Equity Award
Value for Mr.
Clyburn($)
   
Equity Award
Adjustments
for Mr.
Clyburn($)(1)
   
 
SCT Reported
Change in the
Actuarial Present
Value of Pension
Benefits for Mr.
Clyburn($)
   
Pension Benefit
Adjustments
for Mr.
Clyburn($)
   
Compensation
Actually Paid
to Mr.
Clyburn($)
 
2022
    19,271,654       (16,511,105)       12,566,629                   15,327,178  
 
(1)
Represents the year-over-year change in the fair value of equity awards to Mr. Clyburn as summarized below:
 
Year
 
Year End Fair
Value of
Unvested Equity
Awards Granted
in the Year($)
   
Year over Year
Change in Fair
Value of
Outstanding
Unvested Equity
Awards Granted
in Prior Years($)
   
Fair Value as of
Vesting Date of
Equity Awards
Granted and
Vested in the
Year($)
   
Year over Year
Change in Fair
Value of Equity
Awards Granted
in Prior Years
that Vested in
the Year($)
   
Fair Value at the
End of the Prior
Year of Equity
Awards that
Failed to Meet
Vesting
Conditions in
the Year($)
   
 
Value of
Dividends or
other Earnings
Paid on Equity
Awards not
Otherwise
Reflected in Fair
Value or Total
Compensation ($)
   
Total Equity
Award
Adjustments($)
 
2022
    12,566,629                                     12,566,629  
In the table above, the unvested equity values are computed in accordance with the methodology used for financial reporting purposes, and for unvested awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the last day of the year.
Mr. Fibig Compensation
To determine the amounts in column (e) in the PvP table, the following amounts were deducted from and added to (as applicable) Mr. Fibig's total compensation as reported in the Summary Compensation Table ("SCT"), in accordance with Item 402(v) of Regulation
S-K.
 
Year
 
SCT Total for
Mr. Fibig($)
   
SCT Reported
Equity Award
Value for
Mr. Fibig($)
   
Equity Award
Adjustments for
Mr. Fibig($)(1)
   
 
SCT Reported
Change in the
Actuarial Present
Value of Pension
Benefits for
Mr. Fibig($)
   
Pension Benefit
Adjustments for
Mr. Fibig($)
   
Compensation
Actually Paid to
Mr. Fibig($)
 
2022
    11,800,037             (2,888,189)                   8,911,848  
2021
    9,767,380       (5,723,445)       8,481,568                   12,525,503  
2020
    7,731,147       (5,031,869)       1,704,194                   4,403,472  
(1)
Represents t
h
e year-over-year change in the fair value of equity awards to Mr. Fibig as summarized below:
 
Year
 
Year End Fair
Value of Unvested
Equity Awards
Granted in the
Year($)
   
Year over Year
Change in Fair
Value of
Outstanding
Unvested
Equity Awards
Granted in
Prior Years($)
   
Fair Value as of
Vesting Date of
Equity Awards
Granted and
Vested in the
Year($)
   
Year over Year
Change in Fair
Value of Equity
Awards Granted
in Prior Years
that Vested in
the Year($)
   
Fair Value at the
End of the Prior
Year of Equity
Awards that
Failed to Meet
Vesting
Conditions in
the Year($)
   
 
Value of
Dividends or
other Earnings
Paid on Equity
Awards not
Otherwise
Reflected in Fair
Value or Total
Compensation ($)
   
Total Equity
Award
Adjustments($)
 
2022
                      (2,888,189)                   (2,888,189)  
2021
    5,856,147       2,598,655       320,729       642,604       (1,132,404)       195,837       8,481,568  
2020
    3,862,811       (1,093,545)             (471,361)       (771,141)       177,430       1,704,194  
In the table above, the unvested equity values are computed in accordance with the methodology used for financial reporting
p
urposes, and for unvested awards subject to performance-based vesting conditions,
based
on the probable outcome of such performance-based vesting conditions as of the last day of the year.
   
Non-PEO NEO Average Total Compensation Amount $ 5,369,203 $ 3,148,004 $ 2,060,046
Non-PEO NEO Average Compensation Actually Paid Amount $ 3,743,462 3,170,578 1,286,913
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]
Average
Non-CEO
NEO Compensation
To determine the amounts in column (g) in the PvP table, the following amounts were deducted from and added to (as applicable) our
Non-CEO
NEO's average total compensation as reported in the Summary Compensation Table ("SCT"), in accordance with Item 402(v) of Regulation
S-K.
 
Year
 
Average SCT
Total for
Non-CEO

NEOs($)
   
Average SCT
Reported Equity
Award Value for
Non-CEO NEOs($)
   
Average Equity
Award
Adjustments
for
Non-CEO

NEOs ($)(1)
   
 
SCT Reported
Average Change in
the Actuarial
Present Value of
Pension Benefits
for
Non-CEO($)

NEOs($)
   
Average Pension
Benefit
Adjustments for
Non-CEO

NEOs($)(2)
   
Average
Compensation
Actually Paid to
Non-CEO NEOs($)
 
2022
    5,369,203       (3,085,500)       1,459,759                   3,743,462  
2021
    3,148,004       (1,514,851)       1,539,657       (2,232)             3,170,578  
2020
    2,060,046       (1,056,088)       349,261       (66,306)             1,286,913  
 
(1)
Represents the average of the year-over-year change in the fair value of equity awards to
our
Non-CEO
NEO's as summarized below.
 
(2)
There is no service cost or prior service cost adjustment for pension benefits as the pension plan benefits applicable to NEOs were frozen for additional accruals as of December 31, 2007.
 
Year
 
Year End Fair
Value of
Unvested Equity
Awards Granted
in the Year($)
   
Year over Year
Change in Fair
Value of
Outstanding
Unvested
Equity Awards
Granted in
Prior Years($)
   
Fair Value as of
Vesting Date of
Equity Awards
Granted and
Vested in the
Year($)
   
Year over Year
Change in Fair
Value of Equity
Awards Granted
in Prior Years
that Vested in
the Year($)
   
Fair Value at the
End of the Prior
Year of Equity
Awards that
Failed to Meet
Vesting
Conditions in
the Year($)
   
 
Value of
Dividends or
other Earnings
Paid on Equity
Awards not
Otherwise
Reflected in Fair
Value or Total
Compensation
($)
   
Total Equity
Award
Adjustments($)
 
2022
    2,192,872       (220,228)       91,429       (337,314)       (282,833)       15,833       1,459,759  
2021
    1,199,240       198,103       64,492       199,759       (137,688)       15,752       1,539,657  
2020
    733,010       (154,763)             (150,632)       (110,451)       32,097       349,261  
In the table above, the unvested equity values are computed in accordance with the methodology used for financial reporting purposes, and for unvested awards subject to performance-based vesting conditions, based on the probable
outcome
of such performance-based
vesting
conditions as of the last day of the year.
   
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
Compensation Actually Paid ("CAP") vs. IFF
3-year
Cumulative TSR vs. Peer Group
3-year
Cumulative TSR
 
 

As shown in the chart above, the compensation actually paid has increased while the TSR and peer TSR have varied. This is driven largely driven by the
non-equity
incentive plan component of compensation and
sign-on
awards granted to Mr. Clyburn who became CEO in 2022.
   
Compensation Actually Paid vs. Net Income [Text Block]
Compensation Actually Paid ("CAP") vs.
Net-Income
vs. Adjusted
Net-Income
 
 

Adjusted Net Income is included in the chart above as supplemental information as it excludes
one-time
events that have low correlation to compensation actually paid. For 2022, the primary driver of the difference in adjusted net (loss) of ($
1.871
billion) is driven by a $
2.250
billion impairment of goodwill in the Health & Biosciences reporting unit reflected in the net (loss) for 2022.
   
Compensation Actually Paid vs. Company Selected Measure [Text Block]
Compensation Actually Paid ("CAP") vs. Company Selected Measure ("CSM"): Currency Neutral Sales Growth
 
 

 
   
Total Shareholder Return Vs Peer Group [Text Block]
Compensation Actually Paid ("CAP") vs. IFF
3-year
Cumulative TSR vs. Peer Group
3-year
Cumulative TSR
 
 

As shown in the chart above, the compensation actually paid has increased while the TSR and peer TSR have varied. This is driven largely driven by the
non-equity
incentive plan component of compensation and
sign-on
awards granted to Mr. Clyburn who became CEO in 2022.
   
Tabular List [Table Text Block]
Company-Selected Measure and Other Financial Performance Measures
The following financial performance measures are used to link compensation actually paid to NEOs for the most recently completed fiscal years to company performance.
 
Measure
  
Description
Company-Selected Measure
   Currency Neutral Sales Growth
Measure 2
   EBITDA
Measure 3
   Relative TSR
Measure 4
   ROIC
   
Total Shareholder Return Amount $ 88 123 87
Peer Group Total Shareholder Return Amount 110 151 117
Net Income (Loss) $ (1,871,000,000) $ 270,000,000 $ 363,000,000
Company Selected Measure Amount 9.3 7.8 0
Measure [Axis]: 1      
Pay vs Performance Disclosure [Table]      
Measure Name Currency Neutral Sales Growth    
Measure [Axis]: 2      
Pay vs Performance Disclosure [Table]      
Measure Name EBITDA    
Measure [Axis]: 3      
Pay vs Performance Disclosure [Table]      
Measure Name Relative TSR    
Measure [Axis]: 4      
Pay vs Performance Disclosure [Table]      
Measure Name ROIC    
Mr Clyburn [Member]      
Pay vs Performance Disclosure [Table]      
PEO Total Compensation Amount $ 19,271,654    
PEO Actually Paid Compensation Amount $ 15,327,178    
PEO Name Mr. Clyburn    
Mr Fibig [Member]      
Pay vs Performance Disclosure [Table]      
PEO Total Compensation Amount $ 11,800,037 $ 9,767,380 $ 7,731,147
PEO Actually Paid Compensation Amount $ 8,911,848 12,525,503 4,403,472
PEO Name Mr. Fibig    
PEO [Member] | Mr Clyburn [Member] | Reported Equity Award Value [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ (16,511,105)    
PEO [Member] | Mr Clyburn [Member] | Equity Award Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 12,566,629    
PEO [Member] | Mr Clyburn [Member] | Reported Change in the Actuarial Present Value of Pension Benefits [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0    
PEO [Member] | Mr Clyburn [Member] | Pension Benefit Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0    
PEO [Member] | Mr Clyburn [Member] | Year End Fair Value of Unvested Equity Awards Granted in the Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 12,566,629    
PEO [Member] | Mr Clyburn [Member] | Year over Year Change in Fair Value of Outstanding Unvested Equity Awards Granted in Prior Years [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0    
PEO [Member] | Mr Clyburn [Member] | Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0    
PEO [Member] | Mr Clyburn [Member] | Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0    
PEO [Member] | Mr Clyburn [Member] | Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0    
PEO [Member] | Mr Clyburn [Member] | Value of Dividends [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0    
PEO [Member] | Mr Clyburn [Member] | Total Equity Award Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 12,566,629    
PEO [Member] | Mr Fibig [Member] | Reported Equity Award Value [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 (5,723,445) (5,031,869)
PEO [Member] | Mr Fibig [Member] | Equity Award Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (2,888,189) 8,481,568 1,704,194
PEO [Member] | Mr Fibig [Member] | Reported Change in the Actuarial Present Value of Pension Benefits [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 0 0
PEO [Member] | Mr Fibig [Member] | Pension Benefit Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 0 0
PEO [Member] | Mr Fibig [Member] | Year End Fair Value of Unvested Equity Awards Granted in the Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 5,856,147 3,862,811
PEO [Member] | Mr Fibig [Member] | Year over Year Change in Fair Value of Outstanding Unvested Equity Awards Granted in Prior Years [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 2,598,655 (1,093,545)
PEO [Member] | Mr Fibig [Member] | Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 320,729 0
PEO [Member] | Mr Fibig [Member] | Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (2,888,189) 642,604 (471,361)
PEO [Member] | Mr Fibig [Member] | Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 (1,132,404) (771,141)
PEO [Member] | Mr Fibig [Member] | Value of Dividends [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 195,837 177,430
PEO [Member] | Mr Fibig [Member] | Total Equity Award Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (2,888,189) 8,481,568 1,704,194
Non-PEO NEO [Member] | Reported Equity Award Value [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (3,085,500) (1,514,851) (1,056,088)
Non-PEO NEO [Member] | Equity Award Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 1,459,759 1,539,657 349,261
Non-PEO NEO [Member] | Reported Change in the Actuarial Present Value of Pension Benefits [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 (2,232) (66,306)
Non-PEO NEO [Member] | Pension Benefit Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 0 0
Non-PEO NEO [Member] | Year End Fair Value of Unvested Equity Awards Granted in the Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 2,192,872 1,199,240 733,010
Non-PEO NEO [Member] | Year over Year Change in Fair Value of Outstanding Unvested Equity Awards Granted in Prior Years [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (220,228) 198,103 (154,763)
Non-PEO NEO [Member] | Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 91,429 64,492 0
Non-PEO NEO [Member] | Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (337,314) 199,759 (150,632)
Non-PEO NEO [Member] | Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (282,833) (137,688) (110,451)
Non-PEO NEO [Member] | Value of Dividends [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 15,833 15,752 32,097
Non-PEO NEO [Member] | Total Equity Award Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ 1,459,759 $ 1,539,657 $ 349,261